Back to HomeBeta

ICD-10 Coding for Mast Cell Activation Syndrome(D89.41, D89.43)

Complete ICD-10-CM coding and documentation guide for Mast Cell Activation Syndrome. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

MCASMast Cell Activation Disorder

Related ICD-10 Code Ranges

Complete code families applicable to Mast Cell Activation Syndrome

D89.4-D89.49Primary Range

Mast cell activation disorders

This range includes all codes related to mast cell activation syndromes, which are the primary focus for MCAS diagnosis and coding.

Anaphylaxis and angioedema

These codes are used for acute manifestations of MCAS, such as anaphylaxis and angioedema.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
D89.41Mast cell activation syndrome, unspecifiedUse when MCAS is confirmed but not specified as secondary or idiopathic.
  • Serum tryptase level ≥ (1.2 × baseline) + 2 ng/mL
  • Multi-organ involvement documented
D89.43Secondary mast cell activation syndromeUse when MCAS is secondary to another documented condition.
  • Documentation of underlying condition causing MCAS
  • Tryptase elevation during episodes

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for MCAS

Essential facts and insights about Mast Cell Activation Syndrome

The ICD-10 code for mast cell activation syndrome is D89.41 for unspecified cases, with more specific codes like D89.43 for secondary conditions.

Primary ICD-10-CM Codes for mcas

Mast cell activation syndrome, unspecified
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed MCAS with tryptase elevation and multi-organ involvement.

Applicable To

  • Idiopathic MCAS

Excludes

  • Systemic mastocytosis (C94.3)

Clinical Validation Requirements

  • Serum tryptase level ≥ (1.2 × baseline) + 2 ng/mL
  • Multi-organ involvement documented

Code-Specific Risks

  • Risk of using unspecified code when more specific information is available.

Coding Notes

  • Ensure documentation supports the use of this code with specific lab results and symptom descriptions.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Anaphylaxis

T78.2XXA
Use for acute anaphylactic episodes related to MCAS.

Cutaneous flushing

R20.9
Document cutaneous symptoms associated with MCAS.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Systemic mastocytosis

C94.3
Presence of CD117+ mast cell clusters and KIT mutation.

Other mast cell activation disorders

D89.49
Use when MCAS is idiopathic or recurrent without a known secondary cause.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Mast Cell Activation Syndrome to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D89.41.

Impact

Clinical: May lead to misdiagnosis or incomplete treatment., Regulatory: Non-compliance with diagnostic criteria., Financial: Potential for claim denials.

Mitigation Strategy

Ensure comprehensive documentation of all affected systems.

Impact

Reimbursement: May lead to claim denials or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Decreases accuracy of health records.

Mitigation Strategy

Ensure documentation supports the use of specific codes like D89.43 or D89.49.

Impact

Lack of documented tryptase levels can trigger audits.

Mitigation Strategy

Ensure all episodes have corresponding tryptase documentation.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Mast Cell Activation Syndrome, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Mast Cell Activation Syndrome

Use these documentation templates to ensure complete and accurate documentation for Mast Cell Activation Syndrome. These templates include all required elements for proper coding and billing.

MCAS with confirmed tryptase elevation

Specialty: Allergy/Immunology

Required Elements

  • Serum tryptase levels
  • Multi-organ involvement
  • Response to treatment

Example Documentation

ASSESSMENT: Confirmed MCAS with tryptase 18 ng/mL (baseline 12 ng/mL). PLAN: Continue antihistamine therapy.

Examples: Poor vs. Good Documentation

Poor Documentation Example
MCAS likely - will treat
Good Documentation Example
MCAS confirmed per criteria: Tryptase 22 ng/mL during ER visit; resolved with diphenhydramine.
Explanation
The good example provides specific lab results and treatment response, supporting the diagnosis.

Need help with ICD-10 coding for Mast Cell Activation Syndrome? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more